Table 6.
Baseline, post-intervention and follow-up measurements of primary outcome of CORE-OM and its four domains: well-being, symptoms, functioning, risk; and secondary outcome of hair samples
| Baseline | Post-intervention | Follow-up | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | Mean (SD) | Median (min– max) | n | Mean (SD) | Median (min–max) | n | Mean (SD) | Median (min–max) | |
| CORE–OM total | |||||||||
| Support as usual | 38 | 1.67 (.27) | 1. 68 (1.24–2.24) | 38 | 1.78 (.35) | 1.75 (1.18–2.53) | 34 | 1.82 (.35) | 1.79 (1.29–2.74) |
| Face-to–face | 39 | 1.70 (.32) | 1.65 (1.24– 2.65) | 35 | 1.94 (.37) | 1.91 (1.29–2.68) | 33 | 1.81 (.39) | 1.82 (1.29– 2.68) |
| Online | 20 | 1.63 (.33) | 1.57 (1.18– 2.44) | 16 | 1.79 (.35) | 1.79 (1.24–2.41) | 15 | 1.82 (.33) | 1.91 (1.29– 2.29) |
| CORE-OM well-being | |||||||||
| Support as usual | 38 | 1.78 (.40) | 1.75 (1–3) | 38 | 1.91 (.56) | 1.75 (1.00–3.00) | 34 | 1.93 (.56) | 1.75 (1.00–3.50) |
| Face-to-face | 39 | 1.90 (.58) | 1.75 (1–3.5) | 35 | 2.20 (.56) | 2.25 (1.25–3.25) | 33 | 2.05 (.66) | 2.00 (1.00–3.75) |
| Online | 20 | 1.7 (.50) | 2.00 (1–3) | 16 | 1.86 (.52) | 1.88 (1.00–3.00) | 15 | 1.90 (.51) | 2.00 (1.25–2.75) |
| CORE-OM symptoms | |||||||||
| Support as usual | 38 | 1.77 (.39) | 1.79 (1–2.42) | 38 | 1.94 (.53) | 1.79 (1.08–3.00) | 34 | 2.00 (.53) | 1.83 (1.17–3.25) |
| Face-to-face | 39 | 1.82 (.44) | 1.75 (1.25–2.83) | 35 | 2.15 (.52) | 2.08 (1.17–3.00) | 33 | 1.97 (.52) | 1.92 (1.17–3.00) |
| Online | 20 | 1.74 (.46) | 1.67 (1.08–2.83) | 16 | 1.99 (.5) | 1.92 (1.17–3.00) | 15 | 2.00 (.4) | 2.08 (1.33–2.58) |
| CORE-OM functioning | |||||||||
| Support as usual | 38 | 1.80 (.34) | 1.75 (1.33–2.50) | 38 | 1.85 (.35) | 1.83 (1.25–2.92) | 34 | 1.88 (.34) | 1.92 (1.33–2.75) |
| Face-to-face | 39 | 1.76 (.32) | 1.75 (1.33–2.67) | 35 | 1.99 (.44) | 2.00 (1.33–3.17) | 33 | 1.86 (.41) | 1.75 (1.33–2.75) |
| Online | 20 | 1.74 (.36) | 1.67 (1.25–2.5) | 16 | 1.86 (.43) | 1.83 (1.08–2.50) | 15 | 1.93 (.46) | 1.92 (1.08–2.75) |
| CORE-OM risk | |||||||||
| Support as usual | 38 | 1.01 (.04) | 1 (1–1.17) | 38 | 1.01 (.04) | 1.00 (1.00–1.17) | 34 | 1.01 (.04) | 1 (1.00–1.17) |
| Face-to-face | 39 | 1.03 (.08) | 1 (1–1.33) | 35 | 1.02 (.05) | 1.00 (1.00–1.17) | 33 | 1.02 (.05) | 1 (1.00–1.17) |
| Online | 20 | 1.01 (.04) | 1 (1–1.17) | 16 | 1.03 (.13) | 1.00 (1.00–1.5) | 15 | 1.01 (.04) | 1 (1.00–1.17) |
| Hair samples | |||||||||
| Support as usual | 34 | 10.46 (6.70) | 9.52 (1.48–26.81) | 30 | 9.62 (15.84) | 5.30 (1.24–87.62) | 30 | 5.74 (2.99) | 5.43 (0–12.64) |
| Face-to-face | 37 | 15.26 (15.49) | 10.1 (2.81–76.00) | 35 | 9.86 (17.59) | 5.40 (0–103.47) | 32 | 8.46 (12.54) | 4.76 (1.17–55.13) |
| Online | 19 | 11.53 (11.04) | 7.5 (3.12–49.72) | 15 | 5.53 (3.96) | 4.31 (0–13.06) | 13 | 4.27 (2.91) | 3.77 (0–11.51) |